Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
254
days
Epstein‐Barr Virus‐positive NK/T‐cell Malignancies in Poland: Distinctive Features, Therapeutic Strategies, and Survival Insights—The Real‐world Retrospective Report of the Polish Lymphoma Research Group
AuthorsKateryna Filonenko; Ewa Paszkiewicz‐Kozik; Joanna Drozd‐Sokolowska; Marcin Szymanski; Agnieszka Giza; Anna Kopinska; Ewa Chmielowska; Jan Maciej Zaucha
Affiliations1. University Clinical Center Gdańsk Poland; 2. Maria Skłodowska‐Curie National Research Institute of Oncology in Warsaw Warsaw Poland; 3. Medical University of Warsaw Warsaw Poland; 4. Jagiellonian University Medical College Kraków Poland; 5. Medical University of Silesia Katowice Poland; 6. Franciszek Łukaszczyk Oncology Center Bydgoszcz Poland; 7. Nicolaus Copernicus University in Toruń Toruń Poland; 8. Medical University of Gdańsk Gdańsk Poland
31
days
Management of Adult Patients With Isocitrate Dehydrogenase‐Mutant Gliomas in Australia: An Expert Position Statement From the Cooperative Trials Group for Neuro‐Oncology
AuthorsMark B. Pinkham; Hao‐Wen Sim; Rosalind L. Jeffree; Arian Lasocki; Dianne M. Legge; Frank Saran; Laveniya Satgunaseelan; Hui K. Gan
Affiliations1. Department of Radiation Oncology Princess Alexandra Hospital Woolloongabba Queensland Australia; 2. College of Nursing and Health Sciences Flinders University Adelaide South Australia Australia; 3. NHMRC Clinical Trials Centre University of Sydney Camperdown New South Wales Australia; 4. Faculty of Medicine and Health University of New South Wales Kensington New South Wales Australia; 5. Department of Medical Oncology The Kinghorn Cancer Centre Darlinghurst New South Wales Australia; 6. Department of Medical Oncology Chris O'Brien Lifehouse Camperdown New South Wales Australia; 7. Department of Neurosurgery Alfred Hospital Melbourne Victoria Australia; 8. Department of Surgery Monash University Clayton Victoria Australia; 9. Department of Cancer Imaging Peter MacCallum Cancer Centre Melbourne Victoria Australia; 10. Sir Peter Maccallum Department of Oncology The University of Melbourne Parkville Victoria Australia; 11. Department of Radiology The University of Melbourne Parkville Victoria Australia; 12. Brain Tumour Support Service, Olivia Newton‐John Cancer Centre Austin Health Heidelberg Victoria Australia; 13. Faculty of Health Sciences Curtin University Bentley Western Australia Australia; 14. Radiation Oncology Royal Adelaide Hospital Adelaide South Australia Australia; 15. Allied Health and Human Performance University of South Australia Adelaide South Australia Australia; 16. Department of Neuropathology Royal Prince Alfred Hospital Camperdown New South Wales Australia; 17. Brain Cancer Research Chris O'Brien Lifehouse Camperdown New South Wales Australia; 18. Faculty of Medicine and Health, School of Medicine University of Sydney Camperdown New South Wales Australia; 19. Medical Oncology Austin Health Heidelberg Victoria Australia; 20. Cancer Therapies and Biology Lab, Centre for Research Excellence in Brain Cancer Olivia Newton‐John Cancer Research Institute, Austin Health Heidelberg Victoria Australia; 21. Latrobe School of Cancer Medicine Heidelberg Victoria Australia
392
days
Extranodal (Nasal Variant) NK/T ‐Cell Lymphoma of Head and Neck: Our Experience From a Tertiary Care Centre
AuthorsManu C. Balakrishnan; Suvamoy Chakraborty; Zareen Lynrah; Biswajit Dey; Donboklang Lynser; Vikas Jagtap; Anuradha Deka; Sauradeep Das
Affiliations1. Department of Otorhinolaryngology North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences Shillong India; 2. Department of Pathology, North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences Shillong India; 3. Department of Radiology, North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences Shillong India; 4. Department of Radiation Oncology, North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences Shillong India
113
days
Efficacy and Tolerability of Weekly Bortezomib, Lenalidomide, and Dexamethasone Protocols in Transplant‐Ineligible Newly Diagnosed Myeloma: An Australian Real‐World, Multicenter Study
AuthorsSamantha Kurniawan; Angela Hwang; Nicole Wong Doo; Tracy King; Christian Bryant; Jennifer Zhang; Kristina Whelan; Parisa Fani‐Molky; Giselle Kidson‐Gerber; Annmarie Bosco; Nada Hamad; Gurdeep Parmar; Fiona Kwok; Sam Lai; Silvia Ling; P. Joy Ho; Georgia McCaughan; Adam Bryant
Affiliations1. Liverpool Hospital Liverpool Australia; 2. School of Clinical Medicine UNSW Medicine and Health UNSW Sydney Sydney Australia; 3. St Vincent's Hospital Darlinghurst Australia; 4. Concord Repatriation General Hospital Concord Australia; 5. Faculty of Medicine and Health The University of Sydney Sydney Australia; 6. Royal Prince Alfred Hospital Camperdown Australia; 7. Prince of Wales Hospital Randwick Australia; 8. Wollongong Hospital Wollongong Australia; 9. Westmead Hospital Westmead Australia
244
days
Outcomes for Patients With Micro‐Invasive or Small HER2+ Breast Cancer in Northern Sydney Local Health District
AuthorsYuanyuan Xue; Katrina Moore; Tricia Saurine; David Chan; Lina Pugliano; Connie Diakos
Affiliations1. Northern Clinical School The University of Sydney Camperdown New South Wales Australia; 2. Department of Breast Surgery Royal North Shore Hospital St Leonards New South Wales Australia; 3. Department of Anatomical Pathology New South Wales Health Pathology Royal North Shore Hospital St Leonards New South Wales Australia; 4. Department of Medical Oncology Northern Sydney Cancer Centre Royal North Shore Hospital St Leonards New South Wales Australia
63
days
Are Social Media Platforms an Effective Forum for Engaging Early‐Onset Cancer Survivors? Insights From X (Formerly Twitter)
AuthorsAbby Dawson; Savio George Barreto
Affiliations1. College of Medicine and Public Health, Flinders University Adelaide South Australia Australia; 2. Division of Surgery and Perioperative Medicine Flinders Medical Centre Adelaide South Australia Australia
36
days
Management of Advanced Prostate Cancer in the Asia‐Pacific Region: Summary of the Asia‐Pacific Advanced Prostate Cancer Symposium 2025
AuthorsEdmund Chiong; Renu Eapen; Nicholas Buchan; Kenneth Chen; Lukman Hakim; Agus Rizal Hamid; Jae‐Young Joung; Ravindran Kanesvaran; Makarand Khochikar; Jason Letran; Bannakij Lojanapiwat; Indranil Mallick; Chi Fai Ng; Pei Ing Ngam; Teng Aik Ong; Jacob Pang; Darren M. C. Poon; Natasha Roberts; Marniza Saad; Shinichi Sakamoto; Jeremy Tey; Sue Ping Thang; Poh Choo Toh; Levent Türkeri; Nguyễn Tuấn Vinh; Alvin Wong; Yao Zhu; ANZUP Cancer Trials Group; Ian D. Davis
Affiliations1. Department of Urology National University Hospital Singapore Singapore; 2. Department of Surgery Yong Loo Lin School of Medicine National University of Singapore Singapore Singapore; 3. Division of Cancer Surgery Department of Genitourinary Oncology Peter MacCallum Cancer Centre Melbourne Victoria Australia; 4. Department of Urology Christchurch Public Hospital Christchurch New Zealand; 5. Department of Urology Singapore General Hospital Singapore Singapore; 6. Department of Urology Faculty of Medicine Universitas Airlangga Surabaya Indonesia; 7. Department of Medicine Faculty of Medicine and Health Institut Teknologi Sepuluh Nopember Surabaya Indonesia; 8. Department of Urology Faculty of Medicine Universitas Indonesia – Cipto Mangunkusumo Hospital Jakarta Indonesia; 9. Department of Urology Center for Urological Cancer National Cancer Center Goyang South Korea; 10. Division of Medical Oncology National Cancer Centre Singapore Singapore Singapore; 11. Department of Urology/Uro‐oncology Ushakal Abhinav Institute of Medical Sciences Sangli India; 12. Department of Urology Chinese General Hospital and Medical Center Manila Philippines; 13. Department of Surgery Chiang Mai University Chiang Mai Thailand; 14. Department of Radiation Oncology Tata Medical Center Kolkata India; 15. SH Ho Urology Centre The Chinese University of Hong Kong Ma Liu Shu Hong Kong; 16. Department of Diagnostic Imaging National University Hospital Singapore Singapore; 17. Department of Surgery Faculty of Medicine Universiti Malaya Kuala Lumpur Malaysia; 18. Department of Urology Chang Gung Memorial Hospital Linkou Taoyuan Taiwan; 19. Department of Clinical Oncology The Chinese University of Hong Kong Ma Liu Shu Hong Kong; 20. STARS Education and Research Alliance Metro North Health and The University of Queensland Herston Queensland Australia; 21. Department of Clinical Oncology Faculty of Medicine Universiti Malaya Kuala Lumpur Malaysia; 22. Department of Urology Chiba University Graduate School of Medicine Chiba Japan; 23. Department of Radiation Oncology National University Cancer Institute Singapore Singapore Singapore; 24. Department of Nuclear Medicine and Molecular Imaging Singapore General Hospital Singapore Singapore; 25. Department of Urology National University Hospital and Department of Surgery, National University of Singapore Singapore Singapore; 26. Department of Urology Altunizade Hospital, Acibadem M.A. Aydinlar University Istanbul Türkiye; 27. Department of Urology Binh Dan Hospital Ho Chi Minh City Vietnam; 28. Department of Haematology Oncology National University Hospital Singapore Singapore; 29. Department of Urology Fudan University Shanghai Cancer Center Shanghai China; 30. Monash University Melbourne Victoria Australia; 31. Eastern Health Melbourne Victoria Australia
215
days
Cost‐Effectiveness Analysis of Hormone Therapy for Breast Cancer in Japan
AuthorsNaoto Nakagawa; Yuta Chiba; Leanne Lai
Affiliations1. School of Pharmaceutical Sciences Ohu University Koriyama Fukushima Japan; 2. College of Pharmacy Kaohsiung Medical University Kaohsiung City Taiwan
490
days
Global Burden, Quality of Care, and Attributable Risk Factors of Young‐Onset Breast Cancer (YOBC) by WHO Regions: A Systematic Analysis for the Global Burden of Disease Study 2019
AuthorsZhen Yu Wong; Kai Qi Ou; Zhen Ning Wong; Ryan Faderani; Muholan Kanapathy; Afshin Mosahebi
Affiliations1. Queens Medical Centre Nottingham UK; 2. Manipal University College Malaysia Melaka Malaysia; 3. Division of Surgery and Interventional Science University College London London UK
52
days
Oncological Care Needs of People With Mental Illness: A Single Institution Experience in Australia
AuthorsHui‐Ling Yeoh; Wei Hong; Cherelynn Holmes; Michelle M. Y. Leong; Karen Courts; Nicole Potasz; Joanne Lundy; Zee Wan Wong; Richard Newton; Yoland Antill
Affiliations1. Department of Medical Oncology Peninsula Health Frankston Australia; 2. Personalised Oncology Division Walter and Eliza Hall Institute Frankston Australia; 3. Peninsula Clinical School Central Clinical School Faculty of Medicine Nursing and Health Sciences Monash University Frankston Australia; 4. Department of Psychiatry Central Clinical School Peninsula Health Monash University Frankston Australia
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days